Back to today’s briefing

Story perspectives

UCB to Build $5B Biologics Plant, Creating 300 Jobs

6/13/2025

40 5

Summary

Story summary

UCB is set to build a biologics manufacturing facility in the U.S., generating 300 skilled jobs.
The initiative is projected to have a $5 billion economic impact and improve supply chain sustainability.
Since 2017, UCB's U.S. workforce has expanded by 73%, with a 19% revenue increase last year.
This development aligns with industry trends amid potential pharmaceutical tariffs.

1 of 1

Story summary

UCB is set to build a biologics manufacturing facility in the U.S., generating 300 skilled jobs.
The initiative is projected to have a $5 billion economic impact and improve supply chain sustainability.
Since 2017, UCB's U.S. workforce has expanded by 73%, with a 19% revenue increase last year.
This development aligns with industry trends amid potential pharmaceutical tariffs.